Prevention of intrauterine fetal growth restriction by administrating C1q/TNF-related protein 6, a specific inhibitor of the alternative complement pathway
Purpose The latest treatments do not sufficiently prevent miscarriage and fetal growth restriction (FGR) in pregnant women. Here, we assessed the effects of a human protein, CTRP6, that specifically inhibits the activation of the alternative complement pathway on miscarriage, fetal and placental dev...
Saved in:
Published in | Journal of assisted reproduction and genetics Vol. 39; no. 9; pp. 2191 - 2199 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.09.2022
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 1058-0468 1573-7330 1573-7330 |
DOI | 10.1007/s10815-022-02582-1 |
Cover
Abstract | Purpose
The latest treatments do not sufficiently prevent miscarriage and fetal growth restriction (FGR) in pregnant women. Here, we assessed the effects of a human protein, CTRP6, that specifically inhibits the activation of the alternative complement pathway on miscarriage, fetal and placental development.
Methods
Pregnant CBA/J mice mated with DBA/2 male mice as a model of spontaneous abortion and FGR were randomly divided into the control and CTRP6 groups. In the CTRP6 group, the mice were intravenously administered CTRP6 on days 4.5 and 6.5 post-conception (dpc). The abortion rate and fetal and placental weights on 14.5 dpc were examined. Remodeling of the spiral artery was also assessed.
Results
The abortion rate in the CTRP6 group (13%) was reduced compared to the control group (21%), but there was no statistical difference. The placental and fetal weights in the CTRP6 group were also heavier than those in the control (
P
< 0.05). Moreover, the thickness of the blood vessel wall in the CTRP6 group was significantly thinner than that in the control (
P
< 0.05) and comparable to that in the non-abortion model (CBA/J x BALB). The ratio of the inner-per-the-outer diameter of the spiral artery increased more in the CTRP6 group than that in the control (
P
< 0.05). As well, the Th1/Th2 cytokine ratio was significantly reduced by CTRP6 treatment.
Conclusions
Taken together, the supplementation with a protein that regulates the alternative complement pathway in vivo improves FGR and promotes spiral artery remodeling in a mouse model of miscarriage and FGR. |
---|---|
AbstractList | PurposeThe latest treatments do not sufficiently prevent miscarriage and fetal growth restriction (FGR) in pregnant women. Here, we assessed the effects of a human protein, CTRP6, that specifically inhibits the activation of the alternative complement pathway on miscarriage, fetal and placental development.MethodsPregnant CBA/J mice mated with DBA/2 male mice as a model of spontaneous abortion and FGR were randomly divided into the control and CTRP6 groups. In the CTRP6 group, the mice were intravenously administered CTRP6 on days 4.5 and 6.5 post-conception (dpc). The abortion rate and fetal and placental weights on 14.5 dpc were examined. Remodeling of the spiral artery was also assessed.ResultsThe abortion rate in the CTRP6 group (13%) was reduced compared to the control group (21%), but there was no statistical difference. The placental and fetal weights in the CTRP6 group were also heavier than those in the control (P < 0.05). Moreover, the thickness of the blood vessel wall in the CTRP6 group was significantly thinner than that in the control (P < 0.05) and comparable to that in the non-abortion model (CBA/J x BALB). The ratio of the inner-per-the-outer diameter of the spiral artery increased more in the CTRP6 group than that in the control (P < 0.05). As well, the Th1/Th2 cytokine ratio was significantly reduced by CTRP6 treatment.ConclusionsTaken together, the supplementation with a protein that regulates the alternative complement pathway in vivo improves FGR and promotes spiral artery remodeling in a mouse model of miscarriage and FGR. Purpose The latest treatments do not sufficiently prevent miscarriage and fetal growth restriction (FGR) in pregnant women. Here, we assessed the effects of a human protein, CTRP6, that specifically inhibits the activation of the alternative complement pathway on miscarriage, fetal and placental development. Methods Pregnant CBA/J mice mated with DBA/2 male mice as a model of spontaneous abortion and FGR were randomly divided into the control and CTRP6 groups. In the CTRP6 group, the mice were intravenously administered CTRP6 on days 4.5 and 6.5 post-conception (dpc). The abortion rate and fetal and placental weights on 14.5 dpc were examined. Remodeling of the spiral artery was also assessed. Results The abortion rate in the CTRP6 group (13%) was reduced compared to the control group (21%), but there was no statistical difference. The placental and fetal weights in the CTRP6 group were also heavier than those in the control ( P < 0.05). Moreover, the thickness of the blood vessel wall in the CTRP6 group was significantly thinner than that in the control ( P < 0.05) and comparable to that in the non-abortion model (CBA/J x BALB). The ratio of the inner-per-the-outer diameter of the spiral artery increased more in the CTRP6 group than that in the control ( P < 0.05). As well, the Th1/Th2 cytokine ratio was significantly reduced by CTRP6 treatment. Conclusions Taken together, the supplementation with a protein that regulates the alternative complement pathway in vivo improves FGR and promotes spiral artery remodeling in a mouse model of miscarriage and FGR. The latest treatments do not sufficiently prevent miscarriage and fetal growth restriction (FGR) in pregnant women. Here, we assessed the effects of a human protein, CTRP6, that specifically inhibits the activation of the alternative complement pathway on miscarriage, fetal and placental development.PURPOSEThe latest treatments do not sufficiently prevent miscarriage and fetal growth restriction (FGR) in pregnant women. Here, we assessed the effects of a human protein, CTRP6, that specifically inhibits the activation of the alternative complement pathway on miscarriage, fetal and placental development.Pregnant CBA/J mice mated with DBA/2 male mice as a model of spontaneous abortion and FGR were randomly divided into the control and CTRP6 groups. In the CTRP6 group, the mice were intravenously administered CTRP6 on days 4.5 and 6.5 post-conception (dpc). The abortion rate and fetal and placental weights on 14.5 dpc were examined. Remodeling of the spiral artery was also assessed.METHODSPregnant CBA/J mice mated with DBA/2 male mice as a model of spontaneous abortion and FGR were randomly divided into the control and CTRP6 groups. In the CTRP6 group, the mice were intravenously administered CTRP6 on days 4.5 and 6.5 post-conception (dpc). The abortion rate and fetal and placental weights on 14.5 dpc were examined. Remodeling of the spiral artery was also assessed.The abortion rate in the CTRP6 group (13%) was reduced compared to the control group (21%), but there was no statistical difference. The placental and fetal weights in the CTRP6 group were also heavier than those in the control (P < 0.05). Moreover, the thickness of the blood vessel wall in the CTRP6 group was significantly thinner than that in the control (P < 0.05) and comparable to that in the non-abortion model (CBA/J x BALB). The ratio of the inner-per-the-outer diameter of the spiral artery increased more in the CTRP6 group than that in the control (P < 0.05). As well, the Th1/Th2 cytokine ratio was significantly reduced by CTRP6 treatment.RESULTSThe abortion rate in the CTRP6 group (13%) was reduced compared to the control group (21%), but there was no statistical difference. The placental and fetal weights in the CTRP6 group were also heavier than those in the control (P < 0.05). Moreover, the thickness of the blood vessel wall in the CTRP6 group was significantly thinner than that in the control (P < 0.05) and comparable to that in the non-abortion model (CBA/J x BALB). The ratio of the inner-per-the-outer diameter of the spiral artery increased more in the CTRP6 group than that in the control (P < 0.05). As well, the Th1/Th2 cytokine ratio was significantly reduced by CTRP6 treatment.Taken together, the supplementation with a protein that regulates the alternative complement pathway in vivo improves FGR and promotes spiral artery remodeling in a mouse model of miscarriage and FGR.CONCLUSIONSTaken together, the supplementation with a protein that regulates the alternative complement pathway in vivo improves FGR and promotes spiral artery remodeling in a mouse model of miscarriage and FGR. |
Author | Tachibana, Daisuke Takeshita, Ai Koyama, Masayasu Morimoto, Yoshiharu Kurokawa, Mayu Hashimoto, Shu |
Author_xml | – sequence: 1 givenname: Mayu surname: Kurokawa fullname: Kurokawa, Mayu organization: Women’s Lifecare Medicine, Obstetrics and Gynecology, School of Medicine, Osaka City University, Graduate School of Medicine, Reproductive Science, Osaka City University – sequence: 2 givenname: Ai surname: Takeshita fullname: Takeshita, Ai organization: Graduate School of Medicine, Reproductive Science, Osaka City University, Department of Anatomy and Neurobiology, Faculty of Medicine, Kindai University – sequence: 3 givenname: Shu orcidid: 0000-0001-9083-1403 surname: Hashimoto fullname: Hashimoto, Shu email: hashimoto@ivfnamba.com organization: Graduate School of Medicine, Reproductive Science, Osaka City University – sequence: 4 givenname: Masayasu surname: Koyama fullname: Koyama, Masayasu organization: Women’s Lifecare Medicine, Obstetrics and Gynecology, School of Medicine, Osaka City University – sequence: 5 givenname: Yoshiharu surname: Morimoto fullname: Morimoto, Yoshiharu organization: HORAC Grand Front Osaka Clinic – sequence: 6 givenname: Daisuke surname: Tachibana fullname: Tachibana, Daisuke organization: Women’s Lifecare Medicine, Obstetrics and Gynecology, School of Medicine, Osaka City University |
BookMark | eNp9Ustu1TAUjFARfcAPsLLEhgVpj-M4jw0SumoBqQIWZW05zvGNq8RObedW91v4WZzeooouurBsHc_MOR7PaXZkncUse0_hnALUF4FCQ3kORZEWb4qcvspOKK9ZXjMGR-kMvMmhrJrj7DSEWwBom4K9yY4Zb6GGsjnJ_vzyuEMbjbPEaWJs9HKJ6I1FojHKkWy9u48D8RiiN-oB2O2J7CdjTSrJaOyWbOjdxc2Pq9zjKCP2ZPYuorGk-kQkCTMqo41K6oPpTHR-bRUHJHJMrWyS2CFRbppHnNIsZJZxuJf7t9lrLceA7x73s-z31eXN5lt-_fPr982X61zxisa8AQ5VzxnotqRa97JmSFF2IKtC8x4ZlG1XAKiWF22vGNega6p7JbVktWbsLPt80J2XbsJe4WrCKGZvJun3wkkj_r-xZhBbtxNtWZd1RZPAx0cB7-6WZJSYTFA4jtKiW4IoqrZqKkg_kaAfnkFv3ZIsGBOqpiVtoa14QjUHlPIuBI9aKBPl6n3qb0ZBQawJEIcEiJQA8ZAAsc5SPKP-e8eLJHYghQS2W_RPU73A-gszzMhD |
CitedBy_id | crossref_primary_10_1016_j_psj_2024_104538 crossref_primary_10_3390_biomedicines12051128 crossref_primary_10_1152_ajpendo_00353_2024 |
Cites_doi | 10.1002/path.4057 10.1016/j.bbrc.2011.12.057 10.1038/ncomms9483 10.4049/jimmunol.1800058 10.1111/j.1600-0897.2007.00572.x 10.1016/j.jri.2009.06.123 10.3389/fimmu.2019.02317 10.12688/f1000research.11690.1 10.1111/j.1600-0897.2008.00631.x 10.1084/jem.20061022 10.1016/j.molimm.2011.04.011 10.1126/science.2326636 10.1038/srep35138 10.1126/science.281.5380.1191 10.3389/fimmu.2020.02025 10.1016/j.jri.2009.03.004 10.1007/s40620-018-0517-z 10.1038/ni1317 10.1016/j.placenta.2012.09.016 10.1126/science.287.5452.498 10.1016/j.humimm.2007.10.002 10.1093/humrep/del229 10.1111/aji.12682 10.1172/JCI123501 10.1111/aji.12338 10.1093/humrep/dez229 10.1093/humrep/des179 10.1172/JCI68107 10.1002/iub.2272 10.1006/clin.1995.1023 10.1161/CIRCRESAHA.118.313276 10.1007/s00011-016-0968-4 10.1016/j.fertnstert.2019.07.1346 10.1042/BJ20081240 10.1016/j.imbio.2014.01.001 10.1016/j.jaip.2020.03.009 10.1186/1752-0509-9-S2-S4 10.1126/science.1111726 10.1038/srep20073 10.1016/j.jri.2019.07.004 10.1007/s00281-017-0645-x 10.4049/jimmunol.160.2.545 10.1111/j.1600-0897.2010.00846.x |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
DBID | AAYXX CITATION 3V. 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 7X8 5PM |
DOI | 10.1007/s10815-022-02582-1 |
DatabaseName | CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest : Biological Science Collection journals [unlimited simultaneous users] ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Proquest Medical Database Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Central Student MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1573-7330 |
EndPage | 2199 |
ExternalDocumentID | PMC9474761 10_1007_s10815_022_02582_1 |
GrantInformation_xml | – fundername: the Japan Society for the Promotion of Science grantid: 20K09674; 18H06257; 19K18649 – fundername: ; grantid: 20K09674; 18H06257; 19K18649 |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 1SB 2.D 203 28- 29J 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2WC 2~H 30V 3O- 3SX 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67N 67Z 6NX 78A 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACDTI ACGFO ACGFS ACHSB ACHXU ACIHN ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACREN ACUDM ACZOJ ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEAQA AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFGCZ AFKRA AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG AOIJS ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BAWUL BBNVY BBWZM BDATZ BENPR BGNMA BHPHI BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DIK DL5 DNIVK DPUIP DU5 E3Z EBD EBLON EBS EIOEI EJD EMOBN EN4 EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GX1 GXS H13 HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HYE HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAK LK8 LLZTM M1P M4Y M7P MA- N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OK1 OVD P19 P2P P6G PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RNI ROL RPM RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S3A S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 XJT YLTOR Z45 Z7U Z82 Z87 Z8O Z8V Z91 ZGI ZMTXR ZOVNA ~A9 ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT 7XB 8FD 8FK ABRTQ AZQEC DWQXO FR3 GNUQQ K9. P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c561t-80506d530f941ffda73e1eab0a62f5de3049b200c9529dc35f0f71fdcafa37f33 |
IEDL.DBID | AGYKE |
ISSN | 1058-0468 1573-7330 |
IngestDate | Thu Aug 21 18:36:01 EDT 2025 Fri Sep 05 07:29:27 EDT 2025 Fri Jul 25 19:25:47 EDT 2025 Tue Jul 01 02:01:42 EDT 2025 Thu Apr 24 22:53:11 EDT 2025 Fri Feb 21 02:45:27 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | Complement Alternative pathway Spiral artery Abortion Recurrent pregnant failure |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c561t-80506d530f941ffda73e1eab0a62f5de3049b200c9529dc35f0f71fdcafa37f33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0001-9083-1403 |
OpenAccessLink | https://ocu-omu.repo.nii.ac.jp/records/2019949 |
PMID | 35907048 |
PQID | 2714190965 |
PQPubID | 37828 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9474761 proquest_miscellaneous_2696860046 proquest_journals_2714190965 crossref_citationtrail_10_1007_s10815_022_02582_1 crossref_primary_10_1007_s10815_022_02582_1 springer_journals_10_1007_s10815_022_02582_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-09-01 |
PublicationDateYYYYMMDD | 2022-09-01 |
PublicationDate_xml | – month: 09 year: 2022 text: 2022-09-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York |
PublicationSubtitle | An Official Journal of the American Society for Reproductive Medicine |
PublicationTitle | Journal of assisted reproduction and genetics |
PublicationTitleAbbrev | J Assist Reprod Genet |
PublicationYear | 2022 |
Publisher | Springer US Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer Nature B.V |
References | Yang, Zheng, Jin (CR10) 2019; 10 Xu, Mao, Holers, Palanca, Cheng, Molina (CR36) 2000; 287 Nakagawa, Kwak-Kim, Kuroda, Sugiyama, Yamaguchi (CR43) 2017; 78 Tuteja, Cheng, Papadakis, Bejerano (CR25) 2012; 33 Brooks, Radojicic, Riedl, Newcomer, Banerji, Hsu (CR39) 2020; 8 CR14 Sadeghi, Fadaei, Moradi, Fouani, Roozbehkia, Zandieh, Ansaripour, Vatannejad, Doustimotlagh (CR24) 2020; 72 Staff (CR33) 2019; 134–5 Wu, Yang, Feng, Zhang, Li, Wang, Peng, Wang, Xie, Guo, Li, Wang, Zhao, Wang, Wang, Zhang (CR20) 2016; 65 Poveda, Garcés, Ruiz-Linares, Varón, Valderrama, Sanchez, Castiblanco-Cortes, Agudelo-Zapata, Sandoval-Alzate, Leal, Ángel-Müller, Ruíz-Parra, González-Clavijo, Diéguez, Nogueiras, Caminos (CR21) 2016; 6 Munné, Kaplan, Frattarelli, Child, Nakhuda, Shamma, Silverberg, Kalista, Handyside, Katz-Jaffe, Wells, Gordon, Stock-Myer, Willman (CR2) 2019; 112 El Costa, Tabiasco, Berrebi, Parant, Aguerre-Girr, Piccinni, Le Bouteiller (CR9) 2009; 82 Girardi, Prohászka, Bulla, Tedesco, Scherjon (CR15) 2011; 48 Cunningham, Tichenor (CR37) 1995; 74 Wang, Sung, Gilman-Sachs, Kwak-Kim (CR11) 2020; 11 Girardi (CR27) 2008; 59 Trowsdale, Betz (CR7) 2006; 7 Glotov, Tiys, Vashukova, Pakin, Demenkov, Saik, Ivanisenko, Arzhanova, Mozgovaya, Zainulina, Kolchanov, Baranov, Ivanisenko (CR19) 2015; 9 Charalambous, Elia, Georgiades (CR32) 2012; 417 Höchsmann, Murakami, Osato, Knaus, Kawamoto, Inoue, Hirata, Murata, Anliker, Eggermann, Jäger, Floettmann, Höllein, Murase, Ueda, Nishimura, Kanakura, Kohara, Schrezenmeier, Krawitz, Kinoshita (CR41) 2019; 129 Kovats, Main, Librach, Stubblebine, Fisher, DeMars (CR5) 1990; 248 Fraser, Whitley, Johnstone, Host, Sebire, Thilaganathan, Cartwright (CR31) 2012; 228 Moffett, Colucci (CR8) 2014; 124 Redman, Sargent (CR42) 2005; 308 Sugiura-Ogasawara, Nozawa, Nakanishi, Hattori, Ozaki (CR35) 2006; 21 Takeshita, Kusakabe, Hiyama, Kuniyoshi, Kondo, Kano, Kiso, Okada (CR29) 2014; 219 Schumacher, Sharkey, Robertson, Zenclussen (CR30) 2018; 201 Munn, Zhou, Attwood, Bondarev, Conway, Marshall, Brown, Mellor (CR6) 1998; 281 Le Bouteiller, Bensussan (CR4) 2017; 6 Rana, Lemoine, Granger, Karumanchi (CR34) 2019; 124 Sato, Sugiura-Ogasawara, Ozawa, Yamamoto, Kato, Kurahashi, Kuroda, Aoyama, Kato, Kobayashi, Fukuda, Utsunomiya, Kuwahara, Saito, Takeshita, Irahara (CR3) 2019; 34 Vianna, Da Silva, Dos Santos, Bauer, Dalmáz, Bandinelli, Chies (CR18) 2010; 64 Lin, Ren, Wang, Di, Zeng, Saito (CR12) 2009; 82 Girardi (CR38) 2018; 40 van de Geijn, Dolhain, van Rijs, Hazes, de Groot (CR16) 2007; 68 McKelvey, Yenson, Ashton, Morris, McCracken (CR28) 2016; 6 Than, Romero, Erez, Kusanovic, Tarca, Edwin, Kim, Hassan, Espinoza, Mittal, Mazaki-Tovi, Friel, Gotsch, Vaisbuch, Camacho, Papp (CR17) 2008; 60 Wong, Krawczyk, Kitidis-Mitrokostas, Revett, Gimeno, Lodish (CR22) 2008; 416 Sugiura-Ogasawara, Ozaki, Katano, Suzumori, Kitaori, Mizutani (CR1) 2012; 27 Murayama, Kakuta, Inoue, Umeda, Yonezawa, Maruhashi, Tateishi, Ishigame, Yabe, Ikeda, Seno, Chi, Hashiguchi, Kurata, Tada, Kubo, Sato, Liu, Hattori, Saijo, Matsushita, Fujita, Sumida, Iwakura (CR23) 2015; 6 Clark, Chaouat, Arck, Mittruecker, Levy (CR26) 1998; 160 Girardi, Yarilin, Thurman, Holers, Salmon (CR13) 2006; 203 Nakagawa, Kwan-Kim, Ota, Kuroda, Hisano, Sugiyama, Yamaguchi (CR44) 2015; 7 Sarno, Tufano, Maruotti, Martinelli, Balletta, Russo (CR40) 2019; 32 FE van de Geijn (2582_CR16) 2007; 68 L Sarno (2582_CR40) 2019; 32 M Sugiura-Ogasawara (2582_CR35) 2006; 21 P Le Bouteiller (2582_CR4) 2017; 6 AC Staff (2582_CR33) 2019; 134–5 K McKelvey (2582_CR28) 2016; 6 S Munné (2582_CR2) 2019; 112 M Sugiura-Ogasawara (2582_CR1) 2012; 27 F Yang (2582_CR10) 2019; 10 C Xu (2582_CR36) 2000; 287 2582_CR14 G Girardi (2582_CR15) 2011; 48 W Wu (2582_CR20) 2016; 65 H El Costa (2582_CR9) 2009; 82 CW Redman (2582_CR42) 2005; 308 A Takeshita (2582_CR29) 2014; 219 NG Than (2582_CR17) 2008; 60 F Charalambous (2582_CR32) 2012; 417 G Girardi (2582_CR38) 2018; 40 JP Brooks (2582_CR39) 2020; 8 K Nakagawa (2582_CR44) 2015; 7 R Fraser (2582_CR31) 2012; 228 Y Lin (2582_CR12) 2009; 82 P Vianna (2582_CR18) 2010; 64 K Nakagawa (2582_CR43) 2017; 78 G Tuteja (2582_CR25) 2012; 33 S Rana (2582_CR34) 2019; 124 DH Munn (2582_CR6) 1998; 281 GW Wong (2582_CR22) 2008; 416 A Sadeghi (2582_CR24) 2020; 72 W Wang (2582_CR11) 2020; 11 G Girardi (2582_CR13) 2006; 203 B Höchsmann (2582_CR41) 2019; 129 NE Poveda (2582_CR21) 2016; 6 AS Glotov (2582_CR19) 2015; 9 J Trowsdale (2582_CR7) 2006; 7 A Schumacher (2582_CR30) 2018; 201 G Girardi (2582_CR27) 2008; 59 MA Murayama (2582_CR23) 2015; 6 A Moffett (2582_CR8) 2014; 124 DS Cunningham (2582_CR37) 1995; 74 T Sato (2582_CR3) 2019; 34 DA Clark (2582_CR26) 1998; 160 S Kovats (2582_CR5) 1990; 248 |
References_xml | – volume: 228 start-page: 322 year: 2012 end-page: 332 ident: CR31 article-title: Impaired decidual natural killer cell regulation of vascular remodelling in early human pregnancies with high uterine artery resistance publication-title: J Pathol doi: 10.1002/path.4057 – volume: 64 start-page: 359 year: 2010 end-page: 374 ident: CR18 article-title: Association between mannose-binding lectin gene polymorphisms and pre-eclampsia in Brazilian women publication-title: Am J Reprod Immunol – volume: 417 start-page: 847 year: 2012 end-page: 852 ident: CR32 article-title: Decidual spiral artery remodeling during early post-implantation period in mice: investigation of associations with decidual uNK cells and invasive trophoblast publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2011.12.057 – volume: 6 start-page: 8483 year: 2015 ident: CR23 article-title: CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis publication-title: Nat Commun doi: 10.1038/ncomms9483 – volume: 201 start-page: 325 year: 2018 end-page: 334 ident: CR30 article-title: Immune cells at the fetomaternal interface: how the microenvironment modulates immune cells to hoster fetal development publication-title: J Immunol doi: 10.4049/jimmunol.1800058 – volume: 59 start-page: 183 year: 2008 end-page: 192 ident: CR27 article-title: Guilty as charged: all available evidence implicates complement’s role in fetal demise publication-title: Am J Reprod Immunol doi: 10.1111/j.1600-0897.2007.00572.x – volume: 82 start-page: 142 year: 2009 end-page: 147 ident: CR9 article-title: Effector functions of human decidual NK cells in healthy early pregnancy are dependent on the specific engagement of natural cytotoxicity receptors publication-title: J Reprod Immunol doi: 10.1016/j.jri.2009.06.123 – volume: 10 start-page: 2317 year: 2019 ident: CR10 article-title: Dynamic function and composition changes of immune cells during normal and pathological pregnancy at the maternal-fetal interface publication-title: Front Immunol doi: 10.3389/fimmu.2019.02317 – volume: 6 start-page: 1216 year: 2017 ident: CR4 article-title: Up-and-down immunity of pregnancy in humans publication-title: F1000Res doi: 10.12688/f1000research.11690.1 – ident: CR14 – volume: 60 start-page: 333 year: 2008 end-page: 345 ident: CR17 article-title: A role for mannose-binding lectin, a component of the innate immune system in pre-eclampsia publication-title: Am J Reprod Immunol doi: 10.1111/j.1600-0897.2008.00631.x – volume: 203 start-page: 2165 year: 2006 end-page: 2175 ident: CR13 article-title: Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction publication-title: J Exp Med doi: 10.1084/jem.20061022 – volume: 48 start-page: 1621 year: 2011 end-page: 1630 ident: CR15 article-title: Complement activation in animal and human pregnancies as a model for immunological recognition publication-title: Mol Immunol doi: 10.1016/j.molimm.2011.04.011 – volume: 248 start-page: 220 year: 1990 end-page: 223 ident: CR5 article-title: A class I antigen, HLA-G, expressed in human trophoblasts publication-title: Science doi: 10.1126/science.2326636 – volume: 6 start-page: 35138 year: 2016 ident: CR28 article-title: Embryonic/fetal mortality and intrauterine growth restriction is not exclusive to the CBA/J sub-strain in the CBA × DBA model publication-title: Sci Rep doi: 10.1038/srep35138 – volume: 281 start-page: 1191 year: 1998 end-page: 1193 ident: CR6 article-title: Prevention of allogeneic fetal rejection by tryptophan catabolism publication-title: Science doi: 10.1126/science.281.5380.1191 – volume: 11 start-page: 2025 year: 2020 ident: CR11 article-title: T Helper (Th) Cell profiles in pregnancy and recurrent pregnancy losses: Th1/Th2/Th9/Th17/Th22/Tfh cells publication-title: Front Immunol doi: 10.3389/fimmu.2020.02025 – volume: 82 start-page: 12 year: 2009 end-page: 13 ident: CR12 article-title: Effect of TLR3 and TLR7 activation in uterine NK cells from non-obese diabetic (NOD) mice publication-title: J Reprod Immunol doi: 10.1016/j.jri.2009.03.004 – volume: 32 start-page: 17 year: 2019 end-page: 25 ident: CR40 article-title: Eculizumab in pregnancy: a narrative overview publication-title: J Nephrol doi: 10.1007/s40620-018-0517-z – volume: 7 start-page: 241 year: 2006 end-page: 246 ident: CR7 article-title: Mother’s little helpers: mechanisms of maternal-fetal tolerance publication-title: Nat Immunol doi: 10.1038/ni1317 – volume: 33 start-page: 1055 year: 2012 end-page: 1057 ident: CR25 article-title: A comprehensive database of SNPs studied in association with pre-eclampsia publication-title: Placenta doi: 10.1016/j.placenta.2012.09.016 – volume: 287 start-page: 498 year: 2000 end-page: 501 ident: CR36 article-title: A critical role for murine complement regulator crry in fetomaternal tolerance publication-title: Science doi: 10.1126/science.287.5452.498 – volume: 68 start-page: 888 year: 2007 end-page: 893 ident: CR16 article-title: Mannose-binding lectin genotypes and pre-eclampsia: a case-control study publication-title: Hum Immunol doi: 10.1016/j.humimm.2007.10.002 – volume: 160 start-page: 545 year: 1998 end-page: 549 ident: CR26 article-title: Cytokine-dependent abortion in CBA × DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase [correction of prothombinase] publication-title: J Immunol – volume: 21 start-page: 2711 year: 2006 end-page: 2714 ident: CR35 article-title: Complement as a predictor of further miscarriage in couples with recurrent miscarriages publication-title: Hum Reprod doi: 10.1093/humrep/del229 – volume: 78 start-page: e12682 issue: 3 year: 2017 ident: CR43 article-title: Immunosuppressive treatment using tacrolimus promotes pregnancy outcome in infertile women with repeated implantation failures publication-title: Am J Reprod Immunol doi: 10.1111/aji.12682 – volume: 129 start-page: 5123 year: 2019 end-page: 5136 ident: CR41 article-title: Complement and inflammasome overactivation mediates paroxysmal nocturnal hemoglobinuria with autoinflammation publication-title: J Clin Invest doi: 10.1172/JCI123501 – volume: 7 start-page: 353 year: 2015 end-page: 361 ident: CR44 article-title: Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1/TH2 cell ratios publication-title: Am J Reprod Immunol doi: 10.1111/aji.12338 – volume: 34 start-page: 2340 year: 2019 end-page: 2428 ident: CR3 article-title: Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure publication-title: Hum Reprod doi: 10.1093/humrep/dez229 – volume: 27 start-page: 2297 year: 2012 end-page: 2303 ident: CR1 article-title: Abnormal embryonic karyotype is the most frequent cause of recurrent miscarriage publication-title: Hum Reprod doi: 10.1093/humrep/des179 – volume: 124 start-page: 1872 year: 2014 end-page: 1879 ident: CR8 article-title: Uterine NK-cells: active regulators at the maternal-fetal interface publication-title: J Clin Invest doi: 10.1172/JCI68107 – volume: 72 start-page: 1449 year: 2020 end-page: 1459 ident: CR24 article-title: Circulating levels of C1q/TNF-α-related protein 6 (CTRP6) in polycystic ovary syndrome publication-title: IUBMB Life doi: 10.1002/iub.2272 – volume: 74 start-page: 156 year: 1995 end-page: 161 ident: CR37 article-title: Decay-accelerating factor protects human trophoblast from complement-mediated attack publication-title: Clin Immunol Immunopathol doi: 10.1006/clin.1995.1023 – volume: 124 start-page: 1094 year: 2019 end-page: 1112 ident: CR34 article-title: Preeclampsia: pathophysiology, challenges, and perspectives publication-title: Circ Res doi: 10.1161/CIRCRESAHA.118.313276 – volume: 65 start-page: 837 year: 2016 end-page: 845 ident: CR20 article-title: Polymorphisms in complement genes and risk of preeclampsia in Taiyuan publication-title: China Inflamm Res doi: 10.1007/s00011-016-0968-4 – volume: 112 start-page: 1071 year: 2019 end-page: 9 ident: CR2 article-title: Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2019.07.1346 – volume: 416 start-page: 161 year: 2008 end-page: 177 ident: CR22 article-title: Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions publication-title: Biochem J doi: 10.1042/BJ20081240 – volume: 219 start-page: 385 year: 2014 end-page: 391 ident: CR29 article-title: Dynamics and reproductive effects of complement factors in the spontaneous abortion model of CBA/J×DBA/2 mice publication-title: Immunobiology doi: 10.1016/j.imbio.2014.01.001 – volume: 8 start-page: 1875 year: 2020 end-page: 1880 ident: CR39 article-title: Experience with intravenous plasma-derived C1-inhibitor in pregnant women with hereditary angioedema: a systematic literature review publication-title: J Allergy Clin Immunol Pract doi: 10.1016/j.jaip.2020.03.009 – volume: 9 start-page: S4 year: 2015 ident: CR19 article-title: Molecular association of pathogenetic contributors to pre-eclampsia (pre-eclampsia associome) publication-title: BMC Syst Biol doi: 10.1186/1752-0509-9-S2-S4 – volume: 308 start-page: 1592 year: 2005 end-page: 1594 ident: CR42 article-title: Latest advances in understanding preeclampsia publication-title: Science doi: 10.1126/science.1111726 – volume: 6 start-page: 20073 year: 2016 ident: CR21 article-title: Serum adipsin levels throughout normal pregnancy and preeclampsia publication-title: Sci Rep doi: 10.1038/srep20073 – volume: 134–5 start-page: 1 year: 2019 end-page: 10 ident: CR33 article-title: The two-stage placental model of preeclampsia: an update publication-title: J Reprod Immunol doi: 10.1016/j.jri.2019.07.004 – volume: 40 start-page: 103 year: 2018 end-page: 111 ident: CR38 article-title: Complement activation, a threat to pregnancy publication-title: Semin Immunopathol doi: 10.1007/s00281-017-0645-x – volume: 74 start-page: 156 year: 1995 ident: 2582_CR37 publication-title: Clin Immunol Immunopathol doi: 10.1006/clin.1995.1023 – volume: 124 start-page: 1872 year: 2014 ident: 2582_CR8 publication-title: J Clin Invest doi: 10.1172/JCI68107 – volume: 129 start-page: 5123 year: 2019 ident: 2582_CR41 publication-title: J Clin Invest doi: 10.1172/JCI123501 – volume: 112 start-page: 1071 year: 2019 ident: 2582_CR2 publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2019.07.1346 – volume: 6 start-page: 35138 year: 2016 ident: 2582_CR28 publication-title: Sci Rep doi: 10.1038/srep35138 – volume: 228 start-page: 322 year: 2012 ident: 2582_CR31 publication-title: J Pathol doi: 10.1002/path.4057 – volume: 203 start-page: 2165 year: 2006 ident: 2582_CR13 publication-title: J Exp Med doi: 10.1084/jem.20061022 – volume: 65 start-page: 837 year: 2016 ident: 2582_CR20 publication-title: China Inflamm Res doi: 10.1007/s00011-016-0968-4 – volume: 40 start-page: 103 year: 2018 ident: 2582_CR38 publication-title: Semin Immunopathol doi: 10.1007/s00281-017-0645-x – volume: 134–5 start-page: 1 year: 2019 ident: 2582_CR33 publication-title: J Reprod Immunol doi: 10.1016/j.jri.2019.07.004 – volume: 287 start-page: 498 year: 2000 ident: 2582_CR36 publication-title: Science doi: 10.1126/science.287.5452.498 – volume: 82 start-page: 142 year: 2009 ident: 2582_CR9 publication-title: J Reprod Immunol doi: 10.1016/j.jri.2009.06.123 – volume: 160 start-page: 545 year: 1998 ident: 2582_CR26 publication-title: J Immunol doi: 10.4049/jimmunol.160.2.545 – volume: 34 start-page: 2340 year: 2019 ident: 2582_CR3 publication-title: Hum Reprod doi: 10.1093/humrep/dez229 – volume: 10 start-page: 2317 year: 2019 ident: 2582_CR10 publication-title: Front Immunol doi: 10.3389/fimmu.2019.02317 – volume: 281 start-page: 1191 year: 1998 ident: 2582_CR6 publication-title: Science doi: 10.1126/science.281.5380.1191 – volume: 11 start-page: 2025 year: 2020 ident: 2582_CR11 publication-title: Front Immunol doi: 10.3389/fimmu.2020.02025 – volume: 59 start-page: 183 year: 2008 ident: 2582_CR27 publication-title: Am J Reprod Immunol doi: 10.1111/j.1600-0897.2007.00572.x – volume: 308 start-page: 1592 year: 2005 ident: 2582_CR42 publication-title: Science doi: 10.1126/science.1111726 – volume: 78 start-page: e12682 issue: 3 year: 2017 ident: 2582_CR43 publication-title: Am J Reprod Immunol doi: 10.1111/aji.12682 – volume: 219 start-page: 385 year: 2014 ident: 2582_CR29 publication-title: Immunobiology doi: 10.1016/j.imbio.2014.01.001 – volume: 6 start-page: 8483 year: 2015 ident: 2582_CR23 publication-title: Nat Commun doi: 10.1038/ncomms9483 – volume: 7 start-page: 241 year: 2006 ident: 2582_CR7 publication-title: Nat Immunol doi: 10.1038/ni1317 – volume: 21 start-page: 2711 year: 2006 ident: 2582_CR35 publication-title: Hum Reprod doi: 10.1093/humrep/del229 – volume: 72 start-page: 1449 year: 2020 ident: 2582_CR24 publication-title: IUBMB Life doi: 10.1002/iub.2272 – volume: 416 start-page: 161 year: 2008 ident: 2582_CR22 publication-title: Biochem J doi: 10.1042/BJ20081240 – ident: 2582_CR14 – volume: 32 start-page: 17 year: 2019 ident: 2582_CR40 publication-title: J Nephrol doi: 10.1007/s40620-018-0517-z – volume: 33 start-page: 1055 year: 2012 ident: 2582_CR25 publication-title: Placenta doi: 10.1016/j.placenta.2012.09.016 – volume: 417 start-page: 847 year: 2012 ident: 2582_CR32 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2011.12.057 – volume: 7 start-page: 353 year: 2015 ident: 2582_CR44 publication-title: Am J Reprod Immunol doi: 10.1111/aji.12338 – volume: 248 start-page: 220 year: 1990 ident: 2582_CR5 publication-title: Science doi: 10.1126/science.2326636 – volume: 48 start-page: 1621 year: 2011 ident: 2582_CR15 publication-title: Mol Immunol doi: 10.1016/j.molimm.2011.04.011 – volume: 27 start-page: 2297 year: 2012 ident: 2582_CR1 publication-title: Hum Reprod doi: 10.1093/humrep/des179 – volume: 68 start-page: 888 year: 2007 ident: 2582_CR16 publication-title: Hum Immunol doi: 10.1016/j.humimm.2007.10.002 – volume: 9 start-page: S4 year: 2015 ident: 2582_CR19 publication-title: BMC Syst Biol doi: 10.1186/1752-0509-9-S2-S4 – volume: 8 start-page: 1875 year: 2020 ident: 2582_CR39 publication-title: J Allergy Clin Immunol Pract doi: 10.1016/j.jaip.2020.03.009 – volume: 64 start-page: 359 year: 2010 ident: 2582_CR18 publication-title: Am J Reprod Immunol doi: 10.1111/j.1600-0897.2010.00846.x – volume: 201 start-page: 325 year: 2018 ident: 2582_CR30 publication-title: J Immunol doi: 10.4049/jimmunol.1800058 – volume: 82 start-page: 12 year: 2009 ident: 2582_CR12 publication-title: J Reprod Immunol doi: 10.1016/j.jri.2009.03.004 – volume: 60 start-page: 333 year: 2008 ident: 2582_CR17 publication-title: Am J Reprod Immunol doi: 10.1111/j.1600-0897.2008.00631.x – volume: 124 start-page: 1094 year: 2019 ident: 2582_CR34 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.118.313276 – volume: 6 start-page: 1216 year: 2017 ident: 2582_CR4 publication-title: F1000Res doi: 10.12688/f1000research.11690.1 – volume: 6 start-page: 20073 year: 2016 ident: 2582_CR21 publication-title: Sci Rep doi: 10.1038/srep20073 |
SSID | ssj0009823 |
Score | 2.351906 |
Snippet | Purpose
The latest treatments do not sufficiently prevent miscarriage and fetal growth restriction (FGR) in pregnant women. Here, we assessed the effects of a... PurposeThe latest treatments do not sufficiently prevent miscarriage and fetal growth restriction (FGR) in pregnant women. Here, we assessed the effects of a... The latest treatments do not sufficiently prevent miscarriage and fetal growth restriction (FGR) in pregnant women. Here, we assessed the effects of a human... |
SourceID | pubmedcentral proquest crossref springer |
SourceType | Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 2191 |
SubjectTerms | Complement activation Complement component C1q Fetuses Gynecology Human Genetics Lymphocytes T Medicine Medicine & Public Health Miscarriage Placenta Proteins Reproductive Medicine Reproductive Physiology and Disease Supplements Veins & arteries |
SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1RSxwxEA5WQfoi1Sqe1ZKCb3Vxs5tkdx9KqeIhBY9SFHxbkk3iLZSsXk-Kv6V_tjO57G1P0Id7Sm6zbCaTL5mZ7yPkGBBxw3JXJlqLIuG8yRINfZM0VanONYps40HxaiIvb_j3W3G7RiZ9LQymVfY-MThq0zV4R36aFYzD5lVJ8fX-IUHVKIyu9hIaKkormC-BYuwN2QCXXILdb5xdTH78HGh4y2yRci9KTGosYxlNLKYrGVYrZ_ATgDvZ6lY14M_n2ZPPQqhhZxq_I1sRUtJvCxvYJmvW75DNqxg0f0_-9jRNnaedoy0-D4UcoJE6C-Cb3sFZfD6lKNMxa0OhA9VPVP3Hq-vv6Dl7OL2ejJNQ_WINDQwPrafyhCqKBZuYdARPn7YavMQMhwJwSUM43gd6cRry18N9JEUl5D_qaZfcjC-uzy-TqMmQNIC05rChiVQakaeu4sw5o4rcMqt0qmTmhLEYtdOw8ppKZJVpcuFSVzBnGuVUXrg83yPrvvN2n1CZWXApmjtRGe5sqlylEELwwtjSKjkirP_8dRMJy1E341c9UC3jlNUwZXWYspqNyOflf-4XdB2v9j7sZ7WOS_d3PRjaiHxaNsOiw0iK8rZ7hD5IKSTxbmFEihVrWI6KtN2rLb6dBvruisMRTsLgJ73dDIO__K4Hr7_rB_I2C6aL2W-HZH0-e7RHAJfm-mNcA_8AnGoVnw priority: 102 providerName: ProQuest |
Title | Prevention of intrauterine fetal growth restriction by administrating C1q/TNF-related protein 6, a specific inhibitor of the alternative complement pathway |
URI | https://link.springer.com/article/10.1007/s10815-022-02582-1 https://www.proquest.com/docview/2714190965 https://www.proquest.com/docview/2696860046 https://pubmed.ncbi.nlm.nih.gov/PMC9474761 |
Volume | 39 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fa9swEBZrCmMv7X6yrF3RYG-rO0u2JPsxC0nLRsMYDWRPRrKlxqw4beowun9l_-zuFDtpwjbog22wZEmWT9In3913hLwHRJyzyCWBMUIFcZzzwEDeIAx1aCKDQbZxo3g-kmfj-PNETBqnsNvW2r1VSfqZ-p6zW8LQm5jDIQAXwp5nV7AkTTpkt3f6_ctgTbab8KVhvUjQdDFpnGX-XsrmgrRGmds2kluKUr_-DPfJuG350uzkx8miNif5ry1Sx4e-2lOy1wBS2ltK0DPyyFbPyePzRuX-gvxuSZ5mFZ05WmI7MQwEJFJnAbrTS9jJ11OKQT7mpXeToOaO6nusvNUl7bObjxejYeB9Z2xBPT9EWVF5TDVFd080WYLSp6WBOWaOVQE0pV6ZX3lycuqt3_3fTIpxlH_qu5dkPBxc9M-CJqJDkANOq2E5FKEsRBS6NGbOFVpFllltQi25E4VFnZ-BcZungqdFHgkXOsVckWunI-Wi6BXpVLPKviZUcgsTkomdSIvY2VC7VCMAiVVhE6tll7D2s2Z5Q3eOUTeusjVRM_Z6Br2e-V7PWJd8WD1zvST7-G_uw1Zasmbg32ZcsRgwVipFl7xbJcOQRT2MruxsAXmQkEjin4kuURtStqoVSb83U6py6sm_0xg2gBIqP25FaV35v9v65mHZD8gT7qURbekOSaeeL-xbAF-1OSI7aqLgnPTZUTPu4PppMPr6De6eTuDuzpj3_gD82i4I |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELaqIgEXxK9YKGAkONGosWM7yQEhtLDa0u6etlJvwY7tbiSUtNutqn0W3oFnZMabbNhK9NZDTnbsKDMef_bMfEPIB0DEJUt8Fhkj00iIkkcG-kZxrGOTGCyyjQfFyVSNT8SPU3m6Q_50uTAYVtnZxGCobVPiHfkBT5mAzStX8sv5RYRVo9C72pXQWKvFkVtdw5Ht8vPhN5DvR85H32fDcdRWFYhKwApLMMkyVlYmsc8F897qNHHMaRNrxb20Dv1OBnSnzCXPbZlIH_uUeVtqr5PU4wUomPx7IkkUrqJs2IeU5BlfB_TLDEMmszZJp03VyxjmQnN4JKBatr0R9uj2ZmzmDQdt2PdGj8mjFrDSr2sNe0J2XP2U3J-0Lvln5HdHAtXUtPG0wvGwTAQ0Uu8A2tMzOOkv5xSLgCyqkEZBzYrqf1h76zM6ZBcHs-koCrk1ztLAH1HVVO1TTTEdFEOaYPR5ZcAGLXAqgK40OPvrQF5OQ3R8uO2kWGf5Wq-ek5M7kc0Lsls3tXtJqOIODJYRXuZWeBdrn2sEKCK1LnNaDQjrfn9RtnToWJXjV9ETOaPIChBZEURWsAH5tHnnfE0GcmvvvU6qRWsYLotejQfk_aYZljT6aXTtmivog4RFCm8uBiTd0obNrEgKvt1SV_NADp4LOCAqmHy_05t-8v9_66vbv_UdeTCeTY6L48Pp0WvykAc1xji7PbK7XFy5NwDMluZtWA2U_Lzr5fcXdHdMhA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEBYhhdBLSV90m6RVobfGrCVLsn0MaZc0j6WHLORmJEvKGoo23TqE_Jb82cxo7X2EttCDT5Il45mRPmlmviHkMyDimmW-SIyReSJEzRMDfZM01anJDBbZxoPixVidTMTplbxay-KP0e69S3KR04AsTaEd3lg_XEt8KxhmFnN4JGBEOP88g-WYoaZP-NGKdrfgixB7WWAQY9Glzfx5jM2taYU3n0ZLPnGZxp1otEtedBCSHi1k_pJsufCK7Fx0TvLX5KGnZZoFOvO0wfGwcAM0Uu8AbNNrOHu3U4plOeZNTGyg5p7qNR7dcE2P2a_h5XiUxGwXZ2lkdGgCVYdUU0zQxCAjGH3aGFgV5jgVgEka3e8h0onTGK8e7x8pVj6-0_dvyGT07fL4JOlqMCQ1IKsWNjCZKiuz1JeCeW91njnmtEm14l5ah146A5ZWl5KXts6kT33OvK2111nus-wt2Q6z4N4RqriDJcQIL0srvEu1LzVCBpFbVzitBoT1v7-qO4JyrJPxs1pRK6PIKhBZFUVWsQH5snznZkHP8c_e-71Uq85Uf1c8ZwJQUankgHxaNoORoedEBze7hT5IIaTwLmFA8g1tWM6KNN2bLaGZRrruUsCRTcHkh73erCb_-7e-_7_uH8nOj6-j6vz7-GyPPOdRqzEQbp9st_NbdwDIqTUfonE8AnyjEww |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevention+of+intrauterine+fetal+growth+restriction+by+administrating+C1q%2FTNF-related+protein+6%2C+a+specific+inhibitor+of+the+alternative+complement+pathway&rft.jtitle=Journal+of+assisted+reproduction+and+genetics&rft.au=Kurokawa%2C+Mayu&rft.au=Takeshita%2C+Ai&rft.au=Hashimoto%2C+Shu&rft.au=Koyama%2C+Masayasu&rft.date=2022-09-01&rft.pub=Springer+US&rft.issn=1058-0468&rft.eissn=1573-7330&rft.volume=39&rft.issue=9&rft.spage=2191&rft.epage=2199&rft_id=info:doi/10.1007%2Fs10815-022-02582-1&rft.externalDocID=10_1007_s10815_022_02582_1 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1058-0468&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1058-0468&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1058-0468&client=summon |